| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |